Invention Grant
US08952162B2 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
有权
三唑并吡啶类作为治疗皮肤疾病的磷酸二酯酶抑制剂
- Patent Title: Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
- Patent Title (中): 三唑并吡啶类作为治疗皮肤疾病的磷酸二酯酶抑制剂
-
Application No.: US13140505Application Date: 2009-12-18
-
Publication No.: US08952162B2Publication Date: 2015-02-10
- Inventor: Simon Feldbæk Nielsen , Thomas Vifian , Anne Marie Horneman , Jesper Færgemann Lau
- Applicant: Simon Feldbæk Nielsen , Thomas Vifian , Anne Marie Horneman , Jesper Færgemann Lau
- Applicant Address: DK Ballerup
- Assignee: Leo Pharma A/S
- Current Assignee: Leo Pharma A/S
- Current Assignee Address: DK Ballerup
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/DK2009/000262 WO 20091218
- International Announcement: WO2010/069322 WO 20100624
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437
Abstract:
The present invention relates to a compound according to formula I, wherein R1, R2 and A are as defined herein, which exhibit PDE4 inhibitory activity and may be used in the treatment of inflammatory diseases or autoimmune diseases, in particular inflammatory or proliferative dermal diseases.
Public/Granted literature
- US20120028974A1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES Public/Granted day:2012-02-02
Information query
